Interleukin-1β and plasminogen activating system members in endometriotic stromal cell migration/invasion
article
OA: gold
CC0
⤵ 1 in-corpus citation
Abstract
OBJECTIVE: To study the role of interleukin (IL)-1β and the plasminogen activating (PA) system members in endometriotic stromal cell (ESC) migration/invasion.
DESIGN: Primary cultures of ESCs.
SETTING: Tertiary referral center for endometriosis and pelvic pain.
PATIENT(S): Patients with surgically excised endometriosis.
INTERVENTION(S): Interleukin-1β stimulation of primary cultures of ESCs and knockdown of the PA system members urokinase plasminogen activator (uPA), uPA receptor, and plasminogen activator inhibitor-1 (PAI-1).
MAIN OUTCOME MEASURE(S): Invasion/migration assays.
RESULT(S): In primary cultures, IL-1β-stimulated ESC production of the PA system members uPA, uPA receptor, and PAI-1. Interleukin-1β also enhanced ESC migration and invasion, and these effects were inhibited by the IL-1 receptor-1 antagonist anakinra. Knockdown of each of the 3 PA system members also inhibited ESC migration and invasion. Knockdown of these PA system members further attenuated the impact of IL-1β on migration and invasion, suggesting that they mediated the promigration and proinvasion effects of IL-1β. To supplement the cell culture work, immunohistochemistry was performed on tissue sections of endometriotic epithelium/stroma: uPA, PAI-1, and IL-1β histoscores were not found to be correlated with each other.
CONCLUSION(S): In primary cultures of ESCs, IL-1β induces migration and invasion, which is mediated by PA system members and inhibited by the drug anakinra. However, the immunohistochemistry expression of IL-1β, urokinase plasminogen inhibitor-1, and PAI-1 were not correlated, suggesting other regulatory mechanisms for PA system members. Inhibition of IL-1β (e.g., with anakinra) may have potential as a novel treatment approach for the migration/invasion of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Role of interleukin-1β in nerve growth factor expression, neurogenesis and deep dyspareunia in endometriosis 2020
- Endométriose : l’augmentation des concentrations d’interleukine-1β et d’interleukine-1sRII dans le sérum est associée à la forme profonde de cette pathologie 2014
- Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells 2005
Cited by (1)
References (29)
- Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells via openalex
- Endométriose : l’augmentation des concentrations d’interleukine-1β et d’interleukine-1sRII dans le sérum est associée à la forme profonde de cette pathologie via openalex
- Role of interleukin-1β in nerve growth factor expression, neurogenesis and deep dyspareunia in endometriosis via openalex
- W1977671182 via openalex
- W1984200826 via openalex
- W1993667909 via openalex
- W2006028959 via openalex
- W2023205216 via openalex
- W2064947695 via openalex
- W2071096414 via openalex
- W2080801428 via openalex
- W2095847870 via openalex
- W2112455601 via openalex
- W2116232050 via openalex
- W2126035635 via openalex
- W2133557129 via openalex
- W2145489671 via openalex
- W2206304062 via openalex
- W2291960606 via openalex
- W2296497816 via openalex
- W2900531731 via openalex
- W2958827568 via openalex
- W3163107279 via openalex
- W4210698579 via openalex
- W4280622858 via openalex
- W1497890975 via openalex
- W6681583874 via openalex
- W1520699434 via openalex
- W1969850998 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-06-04T00:34:30.390677+00:00
License: CC0
· commercial use OK